Guggenheim Capital LLC Teva Pharmaceutical Industries LTD Transaction History

Guggenheim Capital LLC

$14 Billion
Q3 2024

A detailed history of Guggenheim Capital LLC transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Guggenheim Capital LLC holds 77,308 shares of TEVA stock, worth $1.71 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

77,308

Previous 77,658 0.45%

Holding current value

$1.71 Million

Previous $1.26 Million 10.47%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.81 - $18.96 $5,533 - $6,636	-350 Reduced 0.45%	77,308 $1.39 Million
Q2 2024 Aug 14, 2024	BUY	$12.78 - $17.4 $567,623 - $772,820	44,415 Added 133.61%	77,658 $1.26 Million
Q1 2024 May 14, 2024	BUY	$10.67 - $14.43 $81,412 - $110,100	7,630 Added 29.79%	33,243 $469,000
Q4 2023 Feb 14, 2024	SELL	$8.12 - $10.63 $31,919 - $41,786	-3,931 Reduced 13.31%	25,613 $267,000
Q3 2023 Nov 14, 2023	SELL	$7.48 - $10.7 $90,126 - $128,924	-12,049 Reduced 28.97%	29,544 $301,000
Q2 2023 Aug 11, 2023	SELL	$7.2 - $9.47 $26,964 - $35,465	-3,745 Reduced 8.26%	41,593 $313,000
Q1 2023 May 10, 2023	BUY	$8.36 - $11.37 $379,025 - $515,493	45,338 New	45,338 $401,000
Q4 2021 Feb 14, 2022	SELL	$7.9 - $10.19 $343,357 - $442,887	-43,463 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$8.38 - $10.18 $103,208 - $125,376	12,316 Added 39.54%	43,463 $424,000
Q2 2021 Aug 13, 2021	BUY	$9.9 - $11.56 $52,737 - $61,580	5,327 Added 20.63%	31,147 $309,000
Q1 2021 May 13, 2021	SELL	$10.34 - $12.81 $95,903 - $118,812	-9,275 Reduced 26.43%	25,820 $298,000
Q4 2020 Feb 16, 2021	BUY	$8.61 - $11.04 $302,167 - $387,448	35,095 New	35,095 $338,000
Q4 2019 Feb 14, 2020	SELL	$6.53 - $10.72 $314,778 - $516,757	-48,205 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$6.16 - $9.6 $89,320 - $139,200	-14,500 Reduced 23.12%	48,205 $332,000
Q2 2019 Aug 14, 2019	BUY	$8.12 - $15.72 $94,459 - $182,870	11,633 Added 22.78%	62,705 $579,000
Q1 2019 May 15, 2019	SELL	$15.58 - $20.01 $37,392 - $48,024	-2,400 Reduced 4.49%	51,072 $801,000
Q4 2018 Feb 14, 2019	BUY	$14.59 - $23.84 $3,953 - $6,460	271 Added 0.51%	53,472 $824,000
Q3 2018 Nov 14, 2018	BUY	$21.06 - $25.65 $169,806 - $206,815	8,063 Added 17.86%	53,201 $1.15 Million
Q2 2018 Aug 14, 2018	SELL	$16.77 - $24.71 $193,475 - $285,079	-11,537 Reduced 20.36%	45,138 $1.1 Million
Q1 2018 May 15, 2018	SELL	$16.68 - $22.07 $180,043 - $238,223	-10,794 Reduced 16.0%	56,675 $969,000
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $84,382 - $143,517	-7,514 Reduced 10.02%	67,469 $1.28 Million
Q3 2017 Nov 14, 2017	BUY	$15.41 - $32.17 $1.16 Million - $2.41 Million	74,983	74,983 $1.32 Million

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.5B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guggenheim Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Guggenheim Capital LLC with notifications on news.

Account

Guggenheim Capital LLC Teva Pharmaceutical Industries LTD Transaction History